Income Tax Expense (Benefit) in USD of QLY Biotech Group Corp. from 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
QLY Biotech Group Corp. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to Q1 2023.
  • QLY Biotech Group Corp. Income Tax Expense (Benefit) for the quarter ending February 28, 2023 was $0.000.
  • QLY Biotech Group Corp. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • QLY Biotech Group Corp. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), Annual (USD)

QLY Biotech Group Corp. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $0 Dec 1, 2022 Feb 28, 2023 10-Q 2023-04-13
Q4 2022 $0 Sep 1, 2022 Nov 30, 2022 10-Q 2023-01-13

QLY Biotech Group Corp. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $0 $0 Sep 1, 2021 Aug 31, 2022 10-K 2022-12-14
2021 $0 $0 Sep 1, 2020 Aug 31, 2021 10-K 2022-12-14
2020 $0 Sep 1, 2019 Aug 31, 2020 10-K 2021-11-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.